Russell Investments Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $7.95K | Sell |
|
|||||
|
2023
Q1 | $11.3K | Sell |
|
|||||
|
2022
Q4 | $233K | Buy |
|
|||||
|
2022
Q3 | $129K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $1.11M | Buy |
|
|||||
|
2021
Q3 | $4.14M | Buy |
|
|||||
|
2021
Q2 | $5M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $902K | Buy |
|
|||||
|
2020
Q1 | $219K | Sell |
|
|||||
|
2019
Q4 | $1.06M | Buy |
|
|||||
|
2019
Q3 | $200K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $254K | Buy |
|